Table 1.
Participants’ demographic data.
| CPSP | Stroke Control | Normal Control | p | |
|---|---|---|---|---|
| Subjects, n | 17 | 26 | 34 | |
| Age, years | 57.3 (51.75–62.25) | 53.17 (44.0–67.25) | 57.9 (51.0–64.0) | |
| Female sex, n (%) | 4 (23.5) | 8 (30.8) | 10 (29.4) | 0.867 |
| Stroke type, n (%) | ||||
| Hemorrhage | 9 (52.9) | 14 (53.8) | N/A | 0.954 |
| Infarction | 8 (47.1) | 12 (46.2) | N/A | |
| Brain injury location, n (%) | ||||
| Basal ganglia | 10 (58.8) | 15 (57.7) | N/A | 0.810 |
| Thalamus | 6 (35.3) | 8 (30.8) | N/A | |
| Both | 1 (5.9) | 3 (11.5) | N/A | |
| Stroke side, Left/Right, n (%) | 12/5 (70.6/29.4) | 18/8 (69.2/30.8) | N/A | 0.925 |
| Comorbidity | ||||
| Diabetus Mellitus | 4 (23.5) | 1 (3.8) | 5(14.7) | 0.159 |
| Hypertension | 9 (52.9) | 16 (61.5) | 12 (35.3) | 0.118 |
| Arterial fibrillation | 0 (0) | 2 (7.7) | 0 (0) | 0.133 |
Values are the median (interquartile range: first–third quartiles), or number (n) (%). p-values were tested using Pearson’s chi-square test, CPSP; central post-stroke pain, N/A; not applicable.